Filing Details
- Accession Number:
- 0001209191-17-053521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-20 19:11:02
- Reporting Period:
- 2017-09-18
- Accepted Time:
- 2017-09-20 19:11:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1435049 | Aduro Biotech Inc. | ADRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1653641 | Blaine Templeman | C/O Aduro Biotech, Inc. 740 Heinz Avenue Berkeley CA 94710 | Executive Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-09-18 | 2,884 | $11.20 | 58,834 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.
Billionaire Hedge Funds
